Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 606

1.

Preferences for engagement in health technology assessment decision-making: a nominal group technique with members of the public.

Wortley S, Tong A, Howard K.

BMJ Open. 2016 Feb 1;6(2):e010265. doi: 10.1136/bmjopen-2015-010265.

PMID:
26832433
2.

Stakeholder Views of Clinical Trials in Low- and Middle-Income Countries: A Systematic Review.

Joseph PD, Caldwell PH, Tong A, Hanson CS, Craig JC.

Pediatrics. 2016 Jan 26. pii: peds.2015-2800. [Epub ahead of print] Review.

PMID:
26812926
3.

Eliciting patient preferences, priorities and trade-offs for outcomes following kidney transplantation: a pilot best-worst scaling survey.

Howell M, Wong G, Rose J, Tong A, Craig JC, Howard K.

BMJ Open. 2016 Jan 25;6(1):e008163. doi: 10.1136/bmjopen-2015-008163.

4.

Primary versus Flap Closure of Perineal Defects Following Oncologic Resection: A Systematic Review and Meta Analysis.

Devulapalli C, Tong A, DiBiagio JR, Baez ML, Fallas PB, Seal SM, Sacks JM, Cooney CM, Rosson GD.

Plast Reconstr Surg. 2016 Jan 12. [Epub ahead of print] No abstract available.

PMID:
26796372
5.

Facile electrospinning of an efficient drug delivery system.

Mei L, Wang Y, Tong A, Guo G.

Expert Opin Drug Deliv. 2016 Jan 20. [Epub ahead of print]

PMID:
26787362
6.

Attitudes and beliefs about deceased organ donation in the Arabic-speaking community in Australia: a focus group study.

Ralph AF, Alyami A, Allen RD, Howard K, Craig JC, Chadban SJ, Irving M, Tong A.

BMJ Open. 2016 Jan 19;6(1):e010138. doi: 10.1136/bmjopen-2015-010138.

7.

Real-time patient experience surveys of hospitalized medical patients.

Indovina K, Keniston A, Reid M, Sachs K, Zheng C, Tong A, Hernandez D, Bui K, Ali Z, Nguyen T, Guirguis H, Albert RK, Burden M.

J Hosp Med. 2016 Jan 18. doi: 10.1002/jhm.2533. [Epub ahead of print]

PMID:
26777721
8.

STANDARDISED OUTCOMES IN NEPHROLOGY-HAEMODIALYSIS (SONG-HD): USING THE DELPHI METHOD TO GAIN CONSENSUS ON CORE OUTCOMES FOR HAEMODIALYSIS TRIALS.

Evangelidis N, Craig JC, Tong A; SONG Executive Committee and Investigators.

J Ren Care. 2015 Dec;41(4):211-2. doi: 10.1111/jorc.12144. No abstract available.

PMID:
26768797
9.

Cationic Peptide Conjugation Enhances the Activity of Peroxidase-Mimicking DNAzymes.

Xiao L, Zhou Z, Feng M, Tong A, Xiang Y.

Bioconjug Chem. 2016 Jan 20. [Epub ahead of print]

PMID:
26751843
10.

Of timelines and timeliness: lessons from Typhoon Haiyan in early disaster response.

Santiago JS, Manuela WS Jr, Tan ML, Sañez SK, Tong AZ.

Disasters. 2016 Jan 8. doi: 10.1111/disa.12178. [Epub ahead of print]

PMID:
26748619
11.

Clinicians' Perspectives on Managing Symptom Clusters in Advanced Cancer: A Semistructured Interview Study.

Dong ST, Butow PN, Agar M, Lovell MR, Boyle F, Stockler M, Forster BC, Tong A.

J Pain Symptom Manage. 2015 Dec 28. pii: S0885-3924(15)00991-4. doi: 10.1016/j.jpainsymman.2015.11.021. [Epub ahead of print]

PMID:
26732731
12.

The Consistency and Reporting of Quality-of-Life Outcomes in Trials of Immunosuppressive Agents in Kidney Transplantation: A Systematic Review and Meta-analysis.

Howell M, Wong G, Turner RM, Tan HT, Tong A, Craig JC, Howard K.

Am J Kidney Dis. 2015 Dec 24. pii: S0272-6386(15)01401-8. doi: 10.1053/j.ajkd.2015.11.006. [Epub ahead of print]

PMID:
26724168
13.

KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Psychosocial Care.

Tong A, Mallett A, Lopez-Vargas P, Rangan GK.

Semin Nephrol. 2015 Nov;35(6):590-594.e5. doi: 10.1016/j.semnephrol.2015.10.010. Review. No abstract available.

PMID:
26718163
14.

KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Diet and Lifestyle Management.

Campbell KL, Rangan GK, Lopez-Vargas P, Tong A.

Semin Nephrol. 2015 Nov;35(6):572-581.e17. doi: 10.1016/j.semnephrol.2015.10.008. Review. No abstract available.

PMID:
26718161
15.

KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetics and Genetic Counseling.

Patel C, Tchan M, Savige J, Mallett A, Tong A, Tunnicliffe DJ, Rangan GK.

Semin Nephrol. 2015 Nov;35(6):550-556.e1. doi: 10.1016/j.semnephrol.2015.10.003. Review. No abstract available.

PMID:
26718158
16.

KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetic Testing for Diagnosis.

Tchan M, Savige J, Patel C, Mallett A, Tong A, Tunnicliffe DJ, Rangan GK.

Semin Nephrol. 2015 Nov;35(6):545-549.e2. doi: 10.1016/j.semnephrol.2015.10.007. Review. No abstract available.

PMID:
26718157
17.

Autosomal Dominant Polycystic Kidney Disease: A Path Forward.

Rangan GK, Lopez-Vargas P, Nankivell BJ, Tchan M, Tong A, Tunnicliffe DJ, Savige J.

Semin Nephrol. 2015 Nov;35(6):524-37. doi: 10.1016/j.semnephrol.2015.10.002. Review.

PMID:
26718155
18.

A descriptive analysis of remnant activity during 90Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implications.

Rodríguez LS, Thang SP, Li H, Khor LK, Tay YS, Myint KO, Tong AK.

Ann Nucl Med. 2015 Dec 21. [Epub ahead of print]

PMID:
26692012
19.

The Innate Immune Receptor PGRP-LC Controls Presynaptic Homeostatic Plasticity.

Harris N, Braiser DJ, Dickman DK, Fetter RD, Tong A, Davis GW.

Neuron. 2015 Dec 16;88(6):1157-64. doi: 10.1016/j.neuron.2015.10.049.

PMID:
26687223
20.

Postsynthetic Modification of DNA Phosphodiester Backbone for Photocaged DNAzyme.

Wang X, Feng M, Xiao L, Tong A, Xiang Y.

ACS Chem Biol. 2015 Dec 16. [Epub ahead of print]

PMID:
26669486
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk